Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) EPS (Basic) (2016 - 2025)

Iradimed (IRMD) has disclosed EPS (Basic) for 13 consecutive years, with $0.51 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 24.39% to $0.51 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.77 through Dec 2025, up 15.69% year-over-year, with the annual reading at $1.77 for FY2025, 16.45% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.51 at Iradimed, up from $0.44 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.51 in Q4 2025, with the low at $0.11 in Q1 2021.
  • Average EPS (Basic) over 5 years is $0.32, with a median of $0.33 recorded in 2023.
  • Peak annual rise in EPS (Basic) hit 540.0% in 2021, while the deepest fall reached 26.67% in 2021.
  • Over 5 years, EPS (Basic) stood at $0.32 in 2021, then decreased by 9.37% to $0.29 in 2022, then increased by 24.14% to $0.36 in 2023, then grew by 13.89% to $0.41 in 2024, then increased by 24.39% to $0.51 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $0.51, $0.44, and $0.45 for Q4 2025, Q3 2025, and Q2 2025 respectively.